QNTM ▼ -2.2% - Quantum BioPharma Ltd.
$QNTM - Quantum BioPharma achieve 91% increase in Shareholder Equity and Liquidity in Q3 2026 as Lucid-MS Phase 2 Trial Advances into Study Start-Up
13-NOV-2026 07:05 AM ET
Share this post
More filings for $QNTM
QNTM ▲ +0.5% - Quantum BioPharma Ltd.Nov 11, 2026QNTM ▼ -7.7% - Quantum BioPharma Ltd.Nov 5, 2026QNTM ▼ -0.6% - Quantum BioPharma Ltd.Oct 6, 2026QNTM - Quantum BioPharma Ltd. - SEC Filing Update (05-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 5, 2026QNTM ▲ +1.6% - Quantum BioPharma Ltd.Sep 17, 2026QNTM ▲ +1.7% - Quantum BioPharma Ltd.Sep 15, 2026
View full $QNTM filing history →💬 Comments
Loading comments…
Leave a comment